Stocktoria
CARDINAL HEALTH INC CAH
CARDINAL HEALTH INC (CAH) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the distress zone. It pays a dividend yielding 0.88% (safety: safe). FY2025 revenue was $254.2B at a 0.7% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.74 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-08-12 | Citigroup | Buy (main) |
| 2026-08-12 | Evercore ISI Group | Outperform (main) |
| 2026-08-12 | Morgan Stanley | Overweight (main) |
| 2026-08-12 | Mizuho | Outperform (main) |
| 2026-08-12 | UBS | Buy (main) |
| 2026-08-12 | Wells Fargo | Overweight (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Forward estimates · earnings calendar →
Consensus analyst estimates and scheduled dates — forward-looking, may change.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Wholesale Trade · percentile among 112 companies
Percentile vs other Wholesale Trade companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | -0.048 |
| Retained earnings / assets | 0.015 |
| EBIT / assets | 0.043 |
| Equity / liabilities | -0.05 |
Sector peers · similar-size Wholesale Trade companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| CAH | CARDINAL HEALTH INC | 6/9 | -0.03 | 32.5 | +14.2% |
| MCK | MCKESSON CORP | 6/9 | 0.58 | 18.8 | +12.4% |
| HLF | HERBALIFE LTD. | 5/9 | 0.63 | 5.7 | +0.9% |
| NUS | NU SKIN ENTERPRISES, INC. | 6/9 | 7.36 | 1.6 | -14.3% |
| COSM | Cosmos Health Inc. | 5/9 | -7.92 | — | +19.9% |
| ZSTK | ZeroStack Corp. | — | -13.69 | — | -0.5% |
| WGRX | Wellgistics Health, Inc. | 2/9 | — | — | +28.7% |
All Wholesale Trade companies →
About CARDINAL HEALTH INC
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
FAQ
Is CAH financially healthy?
CARDINAL HEALTH INC's Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does CAH pay a dividend, and is it safe?
Yes. CARDINAL HEALTH INC pays a dividend yielding about 0.88% with a 31.6% payout ratio, rated “safe” for safety.
How profitable is CAH?
In FY2025, CARDINAL HEALTH INC had a net margin of 0.7%.
Is CAH overvalued or undervalued?
CARDINAL HEALTH INC trades at about 32.4× trailing earnings — above its 10-year norm (10-year range 10.1×–72.6×, median 28.5×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for CAH?
The average Wall-Street price target for CARDINAL HEALTH INC is $252.40, about 7.8% above the recent price, from 15 analysts (consensus: strong buy).
Is CAH a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on CARDINAL HEALTH INC: a Piotroski F-score of 6/9, an Altman Z″ in the distress zone, a P/E of about 32.5×, a dividend yield of 0.88%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.